These findings support the notion that dysfunction of the FGF21-adiponectin pathway in adipose tissues occurs at an early stage of glucose metabolic deterioration and participates in the pathophysiology of diabetes in humans. This evidence concerns the gene FGF21 and diabetes mellitus.